1. Soy Intake and Colorectal Cancer Risk: Results from a Pooled Analysis of Prospective Cohort Studies Conducted in China and Japan
- Author
-
Nikhil K. Khankari, Atsushi Goto, Honglan Li, Jae Jeong Yang, Xiao-Ou Shu, Shoichiro Tsugane, Motoki Iwasaki, Wanqing Wen, Jing Gao, Norie Sawada, Gong Yang, Wei Zheng, Taiki Yamaji, Manami Inoue, Taichi Shimazu, and Yong-Bing Xiang
- Subjects
Male ,0301 basic medicine ,China ,medicine.medical_specialty ,Colorectal cancer ,Medicine (miscellaneous) ,Cohort Studies ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Japan ,Risk Factors ,Internal medicine ,medicine ,Humans ,Nutritional Epidemiology ,Prospective Studies ,Prospective cohort study ,Soy protein ,Aged ,030109 nutrition & dietetics ,Nutrition and Dietetics ,Proportional hazards model ,business.industry ,Soy Foods ,Middle Aged ,Isoflavones ,medicine.disease ,Menopause ,chemistry ,030220 oncology & carcinogenesis ,Cohort ,Female ,Colorectal Neoplasms ,business ,Body mass index - Abstract
BACKGROUND: Soy is commonly consumed in east Asian countries and is suggested to reduce colorectal cancer (CRC) risk. However, results from epidemiologic studies are inconsistent, despite the anti-inflammatory and antiproliferative properties of soy isoflavones and soy protein. OBJECTIVE: We evaluated the association between soy isoflavones and soy protein and CRC risk using 4 prospective cohort studies from China and Japan. METHODS: Data were pooled from the Shanghai Women's Health Study (SWHS), Shanghai Men's Health Study (SMHS), Japan Public Health Center–based Prospective Study Cohort 1 (JPHC1), and Cohort 2 (JPHC2). Cox proportional hazards models estimated HRs and corresponding 95% CIs for the association of soy protein and isoflavone intake with CRC risk. The study included 205,060 individuals, among whom 2971 were diagnosed with incident CRC over an average follow-up of 12.7 y. RESULTS: No statistically significant associations with CRC risk were observed for soy protein or isoflavone intake. No association was observed among ever smokers consuming higher isoflavones (HR(isoflavones): 0.83; 95% CI: 0.68, 1.00) and soy protein (HR(soy protein): 0.81; 95% CI: 0.39, 1.10). However, risk reductions were observed among premenopausal women with a body mass index [BMI (kg/m(2))]
- Published
- 2020